NIH HEAL Initiative Virtual Workshop: Toward the Use of Buprenorphine in Infants: Scientific and Practical Considerations

August 06, 2020 - August 24, 2020

Contact: Kathryn Adams
Contact Number: 301-496-8535
Contact Email: Kathryn.adams@nih.gov
Location:

Monday, 8/24/2020 - 10:30am to 3:00pm- Day 1 Videocast
Tuesday, 8/25/2020 - 10:30am to 4:00pm- Day 2 Videocast



Image
NIH HEAL Initiative logo

Buprenorphine is a potential treatment for newborns with neonatal opioid withdrawal syndrome (NOWS). Attendees will discuss both scientific and practical opportunities and issues conducting trials regarding the use of buprenorphine in newborns with NOWS and other pediatric conditions requiring opioid therapy. This meeting is part of the Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, research efforts to enhance outcomes for infants and children exposed to opioids.

Objectives:

  1. Review the state of the science, knowledge gaps, and practical considerations regarding use of buprenorphine in infants for treatment of NOWS
  2. Propose next steps to test the safety and efficacy of buprenorphine for treating NOWS

Registration:

Attendance is free, but registration is required. For more information and to register, visit https://heal.nih.gov/events/2020-buprenorphine-infants.

Individuals with disabilities who need Sign Language Interpreters and/or reasonable accommodation to participate in this event should contact Monica Barnette, 301-459-0100, extension 119, and/or the Federal Relay (1-800-877-8339).

Contacts:

Day 1 Videocast
Day 2 Videocast